Striae Distensae Treatment & Management

  • Author: Samer Alaiti, MD, RVT; Chief Editor: William D James, MD   more...
 
Updated: Aug 17, 2011
 

Medical Care

In current practice, even with the significant dermatologic advances in topical medicaments and light-based devices, total resolution of these lesions remains an unattainable goal.

Avoidance of rapid weight loss or gain may help prevent the emergence of stretch marks, especially in high-risk groups such as teenagers and expecting mothers. Adolescents with striae can expect some improvement in their striae over time.

Striae distensae are most likely to respond to pharmacologic products and clinical interventions at their early stage (striae rubra). Once they become white (striae alba), only few treatment modalities exist and they are become quite difficult to treat.

Intensive moisturization of the lesions and the use of vitamin C, fruit acids, retinols, and other pharmaceuticals has been advocated for the early treatment of striae distensae rubra.

Topical application of tretinoin has been shown to significantly improve the clinical appearance of early striae distensae (striae rubra) as depicted below.[1, 2, 3] It should not, however, be used in pregnant or breastfeeding females owing to a theoretical concern about its teratogenic effects. The use of other retinoids such as adapalene and tazarotene may also hold promise in the treatment of striae distensae.

Significant improvement is achieved using tretinoiSignificant improvement is achieved using tretinoin 0.1% daily for 8 weeks.
Next

Surgical Care

Treatment with the 585-nm flashlamp pulsed dye laser at low energy densities was shown to improve the appearance of striae.[4, 5] Multiple treatments at 4- to 6-week intervals are usually required. At a lower fluence (2-4 J/cm2), the 585-nm flashlamp pulse dye laser (FLPDL) has been purported to increase the amount of collagen in the extracellular matrix. The 585-nm FLPDL has a moderate beneficial effect in reducing the degree of erythema in striae rubra but has no apparent benefit in striae alba. Because of the potential for adverse effects, FLPDL treatments should be performed with extreme caution or even not at all in darker-skinned patients (phototypes V and VI).[6, 7, 8]

A study from Korea evaluated the effectiveness of using 585-nm pulsed dye laser with radiofrequency (Thermage; Hayward, Calif) for striae distensae. Thirty-seven patients with abdominal striae distensae were treated with the Thermage and 585-nm pulsed dye laser in the first session at baseline. An additional 2 sessions of pulsed dye laser therapy were performed at weeks 4 and 8. Thermage was used at a fluence of 53-97 J/cm2, and pulsed dye laser-therapy was used at a fluence of 3 J/cm2 with a 10-mm spot. Skin biopsy specimens were taken from 9 patients.

In the subjective assessment, 89.2% of the patients showed "good" and "very good" overall improvement, and 59.4% were graded as "good" and "very good" in elasticity. All of the 9 specimens showed an increase in the amount of collagen fibers, and increased elastic fibers were found in 6 specimens. The authors reported that Thermage and pulsed dye laser appear to be an effective treatment for striae distensae.[9]

In another study involving the use of a 1064-nm long-pulsed Nd:YAG laser, the authors reported subjective data (55% of patients reported excellent improvement), and objective photographic findings (40% of evaluating physicians reported excellent improvement). Minimal adverse effects were reported.[10]

Intense pulsed light, a noncoherent, nonlaser, filtered flashlamp that emits a broadband visible light, has been reported to yield clinical and microscopical improvement in striae distensae. It seems to be a promising treatment modality with minimal adverse effects and little-to-no down time. Its efficacy in the treatment of photodamaged facial skin has been widely reported; it promotes the production of neocollagen and elastic fibers.[11]

Most of the enhancements in the treatment of striae pertain to striae rubra; only very limited modalities have shown promise in improving the appearance of striae alba. Lasers and light sources emitting UV-B irradiation (eg, the 308-nm excimer laser) have been shown to repigment striae distensae (striae alba). The improvement is due to an increase in melanin pigment, hypertrophy of melanocytes, and an increase in the number of melanocytes.[4]

In another study, a 1550-nm fractional photothermolysis laser was investigated for the treatment of striae distensae alba in Asian patients. Significant improvement in the appearance of the stretch marks was observed 2 months after treatment. Histologic examination revealed a substantial increase in epidermal thickness as well as collagen and elastic fiber deposition. Minimal pain and post treatment hyperpigmentation were the main adverse events reported. Fractional photothermolysis laser treatments appear to improve the appearance of striae distensae alba, particularly through repetitive treatments.[12]

The author had good success using low concentrations (15-20%) of trichloroacetic acid and performing repetitive papillary dermis-level chemexfoliation as shown below. The peels can be repeated at monthly intervals, with improvement in skin texture, firmness, and color.[13]

Significant improvement following 3 consecutive blSignificant improvement following 3 consecutive blue peels (20% trichloroacetic acid to the level of the papillary dermis) completed at 6-week intervals.

A recent publication pertaining to the use of carbon dioxide ablative fractionated lasers in the treatment of striae distensae showed that the benefit has been questionable; the authors stated, "The data were inconclusive regarding the treatment of striae distensae following a series of treatments, with some patients demonstrating significant improvement while others showed no change from baseline."[14]

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Samer Alaiti, MD, RVT  Clinical Associate Professor, Department of Dermatology, Keck School of Medicine of the University of Southern California; Medical Director, Miracle Mile Medical Center for Dermatology and Cosmetic Surgery, Inc

Samer Alaiti, MD, RVT is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American College of Phlebology, American College of Physicians-American Society of Internal Medicine, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and American Society of Lipo-Suction Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Barbara R Reed, MD  Clinical Professor, Department of Dermatology, Dermatology Service, Denver Veterans Affairs Medical Center, University of Colorado Health Sciences Center; Consulting Staff, Denver Skin Clinic

Disclosure: Nothing to disclose.

Richard P Vinson, MD  Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Lester F Libow, MD  Dermatopathologist, South Texas Dermatopathology Laboratory

Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Texas Medical Association

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Zein E. Obagi, MD, to the development and writing of this article.

References
  1. Kang S, Kim KJ, Griffiths CE, Wong TY, Talwar HS, Fisher GJ, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol. May 1996;132(5):519-26. [Medline].

  2. Goldfarb MT, Ellis CN, Weiss JS, Voorhees JJ. Topical tretinoin therapy: its use in photoaged skin. J Am Acad Dermatol. Sep 1989;21(3 Pt 2):645-50. [Medline].

  3. Kligman A. Topical tretinoin: indications, safety, and effectiveness. Cutis. Jun 1987;39(6):486-8. [Medline].

  4. Goldberg DJ, Marmur ES, Schmults C, et al. Histologic and ultrastructural analysis of ultraviolet B laser and light source treatment of leukoderma in striae distensae. Dermatolog Surg. 2005;31(4):385-7. [Medline].

  5. Fox JL. Pulse dye laser eliminates stretch marks. Cosmetic Dermatology. 1997;10:51-2.

  6. Jimenez GP, Flores F, Berman B, Gunja-Smith Z. Treatment of striae rubra with the 585-nm pulsed-dye laser. Dermatol Surg. 2003;29(4):362-5. [Medline].

  7. McDaniel DH, Ash K, Zukowski M. Treatment of stretch marks with the 585-nm flashlamp-pumped pulsed dye laser. Dermatol Surg. Apr 1996;22(4):332-7. [Medline].

  8. McDaniel DH. Laser therapy of stretch marks. Dermatol Clin. 2002;20:67-76. [Medline].

  9. Suh DH, Chang KY, Son HC, Ryu JH, Lee SJ, Song KY. Radiofrequency and 585-nm pulsed dye laser treatment of striae distensae: a report of 37 Asian patients. Dermatol Surg. Jan 2007;33(1):29-34. [Medline].

  10. Goldman A, Rossato F, Prati C. Stretch marks: treatment using the 1,064 nm Nd:YAG. laser. Dermatol Surg. May 2008;34(5):686-91.

  11. Hernandez-Perez E, Colombo-Charrier E, Valencia-Ibiett E. Intense pulsed light in the treatment of striae distensae. Dermatol Surg. 2002;28(12):1124-30. [Medline].

  12. Kim BJ, Lee DH, Kim MN, Song KY, Cho WI, Lee CK, et al. Fractional photothermolysis for the treatment of striae distensae in Asian skin. Am J Clin Dermatol. 2008;9(1):33-7.

  13. Obagi ZE, Obagi S, Alaiti S, Stevens MB. TCA-based blue peel: a standardized procedure with depth control. Dermatol Surg. Oct 1999;25(10):773-80. [Medline].

  14. Alexiades-Armenaka M, Sarnoff D, Gotkin R, Sadick N. Multi-center clinical study and review of fractional ablative CO2 laser resurfacing for the treatment of rhytides, photoaging, scars and striae. J Drugs Dermatol. Apr 2011;10(4):352-62. [Medline].

  15. Arnold HL, Odom RB, James WD. Abnormalities of dermal connective tissue. In: Odom RB, James WD, Berger TG, eds. Andrew's Diseases of the Skin Clinical Dermatology. 9th ed. Philadelphia, Pa: WB Saunders; 2000:645-6.

  16. Burton Jl, Lovell CR. Disorders of connective tissue. In: Champion RH, Wilkinson DS, Ebling FJG, et al, eds. Textbook of Dermatology. 6th ed. London, England: Blackwell Science; 1998:2008-9.

  17. Dover JS. Sports dermatology. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1618-19.

  18. Medical Economics Staff. Physician's Desk Reference. 53rd ed. Montvale, NJ: Medical Economics Company; 1999:2177.

Previous
Next
 
Mature striae distensae on the abdomen following pregnancy (lesions present for 18 y).
Significant improvement following 3 consecutive blue peels (20% trichloroacetic acid to the level of the papillary dermis) completed at 6-week intervals.
Striae distensae on the thigh.
Striae distensae after treatment with topical tretinoin 0.1% cream for 3 months and 2 treatments with the flashlamp pulsed dye laser.
Mature striae distensae on the abdomen secondary to pregnancy (lesions present for 21 y).
Significant improvement is achieved using tretinoin 0.1% daily for 8 weeks.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.